TABLE 1.
Baseline characteristics of study participants, 2014–2019
Characteristics | Year | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||
2014–2017 | 2018–2019 | Overall (2014–2019) | ||||||||||
|
|
|
||||||||||
Total | IPT | No IPT | P value | Total | IPT | No IPT | P value | Total | IPT | No IPT | P value | |
Overall coverage | 20,554 | 5,149 (25.0) | 15,405 (75.0) | — | 5,586 | 2,401 (43.0) | 3,185 (57.0) | — | 26,140 | 7,550 (28.9) | 18,590 (71.1) | — |
Sex | ||||||||||||
Female | 14,821 | 3,716 (25.1) | 11,105 (74.9) | 0.909 | 3,741 | 1,636 (43.7) | 2,105 (56.3) | 0.107 | 18,562 | 5,352 (28.8) | 13,210 (71.2) | 0.781 |
Male | 5,733 | 1,433 (25.0) | 4,300 (75.0) | 1,845 | 765 (41.5) | 1,080 (58.5) | 7,578 | 2,198 (29.0) | 5,380 (71.0) | |||
Age groups, years | ||||||||||||
18–24 | 2,450 | 479 (19.6) | 1,971 (80.4) | <0.001 | 705 | 262 (37.2) | 443 (62.8) | <0.001 | 3,155 | 741 (23.5) | 2,414 (76.5) | <0.001 |
25–34 | 7,167 | 1,698 (23.7) | 5,469 (76.3) | 1,919 | 782 (40.8) | 1137 (59.2) | 9,086 | 2,480 (27.3) | 6,606 (72.7) | |||
35–44 | 6,599 | 1,802 (27.3) | 4,797 (72.7) | 1,783 | 839 (47.1) | 944 (52.9) | 8,382 | 2,641 (31.5) | 5,741 (68.5) | |||
45–54 | 3,057 | 881 (28.8) | 4,797 (71.2) | 842 | 374 (44.4) | 468 (55.6) | 3,899 | 1,255 (32.2) | 2,644 (67.8) | |||
55–64 | 959 | 239 (24.9) | 720 (75.1) | 256 | 115 (44.9) | 141 (55.1) | 1,215 | 354 (29.1) | 861 (70.9) | |||
65+ | 322 | 50 (15.5) | 272 (84.5) | 81 | 29 (35.8) | 52 (64.2) | 403 | 70 (19.6) | 324 (80.4) | |||
Binary age group, years | ||||||||||||
18–35 | 10,393 | 2,387 (23.0) | 8,006 (77.0) | <0.001 | 2,828 | 1,134 (40.1) | 1,694 (59.9) | <0.001 | 13,221 | 3,521 (26.6) | 9,700 (73.4) | <0.001 |
>36 | 10,161 | 2,762 (27.2) | 7,399 (72.8) | 2,760 | 1,267 (45.9) | 1,491 (54.1) | 12,919 | 4,029 (31.2) | 8,890 (68.8) | |||
BMI, kg/m2 | ||||||||||||
<18.5 (under-weight) | 2,754 | 563 (12.4) | 2,191 (16.2) | <0.001 | 574 | 187 (32.6) | 387 (67.4) | <0.001 | 3,328 | 750 (22.5) | 2,578 (77.5) | <0.001 |
18.5–24.9 (normal weight) | 9,839 | 2,524 (55.4) | 7,315 (54.0) | 2,723 | 1,135 (41.7) | 1,588 (58.3) | 12,562 | 3,659 (29.1) | 8,903 (70.9) | |||
25.0–29.9 (overweight) | 3,643 | 971 (21.3) | 2,672 (19.7) | 953 | 471 (49.4) | 482 (50.6) | 4,596 | 1,442 (31.4) | 3,154 (68.6) | |||
>30 (obese) | 1,854 | 494 (10.9) | 1,360 (10.0) | 573 | 287 (50.1) | 286 (49.9) | 2,427 | 781 (32.2) | 1,646 (67.8) | |||
Size of health facility | ||||||||||||
Low volume | 4,724 | 1,172 (24.8) | 3,552 (75.2) | 0.001 | 1,431 | 590 (41.2) | 841 (58.8) | <0.001 | 6,255 | 1,762 (28.6 | 4,393 (71.4) | <0.001 |
Medium volume | 6,966 | 1,850 (26.6) | 5,116 (73.4) | 1,930 | 980 (50.8) | 950 (49.2) | 8,896 | 2,830 (31.8) | 6,066 (68.2) | |||
High volume | 8,874 | 2,132 (24.0) | 6,742 (76.0) | 2,218 | 827 (37.3) | 1,391 (62.7) | 11,092 | 2,959 (26.7) | 8,133 (73.3) |
IPT = isoniazid preventive therapy; BMI = body mass index.